ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Hydrochloric Acid → 4-(3-Aminoazetidin-1-yl)-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5,5-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one

HRID 536532
印刷

反応式

HRID 536532 の反応式
Cl.C(OC(=O)[NH:8][CH:9]1[CH2:12][N:11]([C:13]2[C:14]3[C:38]([CH3:40])([CH3:39])[C:37](=[O:41])[NH:36][C:15]=3[N:16]=[C:17]([C:19]3[C:27]4[C:22](=[N:23][CH:24]=[CH:25][CH:26]=4)[N:21]([CH2:28][C:29]4[CH:34]=[CH:33][CH:32]=[CH:31][C:30]=4[F:35])[N:20]=3)[N:18]=2)[CH2:10]1)(C)(C)C>C(OCC)C>[NH2:8][CH:9]1[CH2:10][N:11]([C:13]2[C:14]3[C:38]([CH3:39])([CH3:40])[C:37](=[O:41])[NH:36][C:15]=3[N:16]=[C:17]([C:19]3[C:27]4[C:22](=[N:23][CH:24]=[CH:25][CH:26]=4)[N:21]([CH2:28][C:29]4[CH:34]=[CH:33][CH:32]=[CH:31][C:30]=4[F:35])[N:20]=3)[N:18]=2)[CH2:12]1
参加物実験手順後処理出典と根拠反応ノート

参加物

4

反応物 2

HCID 313Hydrochloric AcidHCID 71290302tert.-Butyl-(1-{2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5,5-dimethyl-6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl}azetidin-3-yl)carbamate

生成物 1

HCID 712857714-(3-Aminoazetidin-1-yl)-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5,5-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one

試薬・触媒・溶媒 1

HCID 3283Diethyl Ether溶媒

実験手順

0.66 ml of a 2N solution of hydrogen chloride in diethyl ether was added to 81 mg (0.13 mmol; purity 91%) of tert.-butyl-(1-[2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5,5-dimethyl-6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]azetidin-3-yl)carbamate (example 62A) and it was stirred for 4 h at room temperature. The reaction solution was concentrated by evaporation and purified twice by preparative HPLC (acetonitrile/water (+0.1% trifluoroacetic acid) gradient). The concentrated fractions were dissolved in dichloromethane and washed twice with saturated aqueous sodium hydrogen carbonate solution. The combined aqueous phases were extracted twice with dichloromethane. The combined organic phases were dried over sodium sulphate, filtered and concentrated by evaporation. 31 mg (49% of theor.) of the target compound was obtained.

後処理

  1. concentrationThe reaction solution was concentrated by evaporation
  2. custompurified twice by preparative HPLC (acetonitrile/water (+0.1% trifluoroacetic acid) gradient)
  3. dissolutionThe concentrated fractions were dissolved in dichloromethane
  4. washwashed twice with saturated aqueous sodium hydrogen carbonate solution
  5. extractionThe combined aqueous phases were extracted twice with dichloromethane
  6. dry with materialThe combined organic phases were dried over sodium sulphate
  7. filtrationfiltered
  8. concentrationconcentrated by evaporation
  9. custom31 mg (49% of theor.) of the target compound was obtained

出典と根拠

ORDレコード
ord-50f58b52677f4bf184d8420b134ccb3b
出典データセット
uspto-grants-2014_10
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08859569B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート